Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting Breast Cancer Stem Cells: A Methodological Perspective.
Velasco-Velázquez MA, Velázquez-Quesada I, Vásquez-Bochm LX, Pérez-Tapia SM. Velasco-Velázquez MA, et al. Among authors: velazquez quesada i. Curr Stem Cell Res Ther. 2019;14(5):389-397. doi: 10.2174/1574888X13666180821155701. Curr Stem Cell Res Ther. 2019. PMID: 30147014 Review.
Virtual screening-driven repositioning of etoposide as CD44 antagonist in breast cancer cells.
Aguirre-Alvarado C, Segura-Cabrera A, Velázquez-Quesada I, Hernández-Esquivel MA, García-Pérez CA, Guerrero-Rodríguez SL, Ruiz-Moreno AJ, Rodríguez-Moreno A, Pérez-Tapia SM, Velasco-Velázquez MA. Aguirre-Alvarado C, et al. Oncotarget. 2016 Apr 26;7(17):23772-84. doi: 10.18632/oncotarget.8180. Oncotarget. 2016. PMID: 27009862 Free PMC article.
Pranlukast Antagonizes CD49f and Reduces Stemness in Triple-Negative Breast Cancer Cells.
Velázquez-Quesada I, Ruiz-Moreno AJ, Casique-Aguirre D, Aguirre-Alvarado C, Cortés-Mendoza F, de la Fuente-Granada M, García-Pérez C, Pérez-Tapia SM, González-Arenas A, Segura-Cabrera A, Velasco-Velázquez MA. Velázquez-Quesada I, et al. Drug Des Devel Ther. 2020 May 12;14:1799-1811. doi: 10.2147/DDDT.S247730. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32494122 Free PMC article.
Matrix-Targeting Immunotherapy Controls Tumor Growth and Spread by Switching Macrophage Phenotype.
Deligne C, Murdamoothoo D, Gammage AN, Gschwandtner M, Erne W, Loustau T, Marzeda AM, Carapito R, Paul N, Velazquez-Quesada I, Mazzier I, Sun Z, Orend G, Midwood KS. Deligne C, et al. Among authors: velazquez quesada i. Cancer Immunol Res. 2020 Mar;8(3):368-382. doi: 10.1158/2326-6066.CIR-19-0276. Epub 2020 Jan 15. Cancer Immunol Res. 2020. PMID: 31941671 Free PMC article.
Tenascin-C Orchestrates Glioblastoma Angiogenesis by Modulation of Pro- and Anti-angiogenic Signaling.
Rupp T, Langlois B, Koczorowska MM, Radwanska A, Sun Z, Hussenet T, Lefebvre O, Murdamoothoo D, Arnold C, Klein A, Biniossek ML, Hyenne V, Naudin E, Velazquez-Quesada I, Schilling O, Van Obberghen-Schilling E, Orend G. Rupp T, et al. Among authors: velazquez quesada i. Cell Rep. 2016 Dec 6;17(10):2607-2619. doi: 10.1016/j.celrep.2016.11.012. Cell Rep. 2016. PMID: 27926865 Free article.
Tenascin-C increases lung metastasis by impacting blood vessel invasions.
Sun Z, Velázquez-Quesada I, Murdamoothoo D, Ahowesso C, Yilmaz A, Spenlé C, Averous G, Erne W, Oberndorfer F, Oszwald A, Kain R, Bourdon C, Mangin P, Deligne C, Midwood K, Abou-Faycal C, Lefebvre O, Klein A, van der Heyden M, Chenard MP, Christofori G, Mathelin C, Loustau T, Hussenet T, Orend G. Sun Z, et al. Among authors: velazquez quesada i. Matrix Biol. 2019 Oct;83:26-47. doi: 10.1016/j.matbio.2019.07.001. Epub 2019 Jul 6. Matrix Biol. 2019. PMID: 31288084 Free article.
Tenascin-C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression.
Murdamoothoo D, Sun Z, Yilmaz A, Riegel G, Abou-Faycal C, Deligne C, Velazquez-Quesada I, Erne W, Nascimento M, Mörgelin M, Cremel G, Paul N, Carapito R, Veber R, Dumortier H, Yuan J, Midwood KS, Loustau T, Orend G. Murdamoothoo D, et al. Among authors: velazquez quesada i. EMBO Mol Med. 2021 Jun 7;13(6):e13270. doi: 10.15252/emmm.202013270. Epub 2021 May 14. EMBO Mol Med. 2021. PMID: 33988305 Free PMC article.
DACIT: Device for Axon - Cancer cell Interaction Testing in 2D and 3D.
Velazquez-Quesada I, Allison K, Alizadeh V, Hesketh N, Thomas G, Tuzel E, Gligorijevic B. Velazquez-Quesada I, et al. bioRxiv [Preprint]. 2024 Mar 1:2024.02.26.582218. doi: 10.1101/2024.02.26.582218. bioRxiv. 2024. PMID: 38464088 Free PMC article. Preprint.
13 results